NextFin news, Asian stock markets experienced a significant selloff on Friday, September 26, 2025, as unexpected U.S. tariff announcements and diminishing expectations for Federal Reserve interest rate cuts unsettled investors across the region. The tariff measures, including a 100% duty on imported branded pharmaceuticals, triggered sharp declines in healthcare stocks, while robust U.S. economic data reduced optimism for near-term rate reductions, pressuring growth-oriented sectors.
Japan's Nikkei 225 index dropped 0.87% to 45,354.99, marking its first decline in four sessions. Meanwhile, Hong Kong's Hang Seng Index fell 1.4%, with its tech-heavy sub-index plunging 2.9%, resulting in the first weekly loss for the Hang Seng in September. China's Shanghai Composite and CSI 300 indexes declined 0.7% and 1.0%, respectively. South Korea's Kospi suffered its worst one-day loss in months, tumbling 2.45% to 3,386.05, amid heavy foreign selling and concerns over trade relations with the U.S. India's Sensex and Nifty 50 each fell approximately 0.9%, culminating in the worst week for Indian equities in nearly two months.
The technology and healthcare sectors bore the brunt of the downturn. Pharmaceutical stocks across Asia were hit hard following the U.S. tariff announcement. India's Nifty Pharma index dropped 2.2%, with major drugmakers like Sun Pharma and Dr. Reddy's Laboratories retreating. Japan's pharmaceutical sub-index declined about 1.2%, while Hong Kong biotech firms such as Wuxi Biologics and Wuxi AppTec fell 2.4% and 3.3%, respectively. Technology stocks also suffered, with South Korean giants Samsung Electronics and SK Hynix falling 3.3% and 5.6%. Taiwan's TSMC declined 1.5%, and Xiaomi shares collapsed 8.1% after initial gains on a new smartphone launch evaporated.
Foreign investors withdrew from emerging Asian markets, notably South Korea and India, driving the Korean won to a four-month low near ₩1,412 per U.S. dollar. The selloff reflected a flight to safety amid concerns over trade tensions and the prospect of sustained higher U.S. interest rates. The U.S. dollar index rose about 0.7% for the week, while the Japanese yen hovered near ¥150 per dollar, a level that has previously prompted intervention considerations by Japanese authorities.
The tariff package announced by U.S. President Donald Trump, effective October 1, includes a 100% tariff on branded pharmaceuticals, 25% on heavy trucks, and 50% on certain furniture items. The tariffs, justified under national security provisions, caught markets off guard and raised fears of retaliatory trade measures and increased costs for Asian exporters. South Korean trade talks with the U.S. have also stalled, with uncertainty over a $350 billion Korean investment in the U.S. adding to market jitters.
Robust U.S. economic data, including stronger-than-expected durable goods orders and an upward revision to second-quarter GDP, diminished expectations for aggressive Federal Reserve rate cuts. This shift in outlook contributed to higher bond yields and a stronger dollar, further pressuring Asian equities. Market strategists noted that optimism for multiple rate reductions in 2024 has faded, with expectations now limited to at most four cuts, if any.
Despite the broad selloff, some sectors showed resilience. Energy and commodities-related stocks benefited from rising oil prices, with Brent crude nearing $69.5 per barrel, marking the largest weekly gain in three months. Indian conglomerate Reliance Industries gained about 1%, supported by the oil rally. Banking stocks in Singapore and India also limited losses, benefiting from higher interest rates that improve net interest margins.
Market experts advised caution amid the heightened volatility. Stephen Innes, managing partner at SPI Asset Management, remarked that equity valuations had been buoyed by hopes for lower interest rates but are now correcting as those expectations wane. In India, strategists recommended a stock-specific approach, focusing on quality names amid external uncertainties. Currency strategists warned of potential intervention risks if the yen's weakness persists, while South Korea's central bank remains prepared to manage won volatility.
Looking ahead, investors are closely monitoring upcoming economic data, including U.S. inflation measures and employment reports, as well as China's manufacturing PMI and the Communist Party's October plenum, which will outline the country's economic direction. Corporate earnings season is also anticipated to influence market sentiment. Analysts expect continued short-term volatility but see opportunities for selective buying if fundamentals remain intact.
In summary, the Asian markets' downturn on September 26, 2025, was driven by a combination of unexpected U.S. trade policy actions and shifting monetary policy expectations. The resulting broad-based selloff underscores the sensitivity of regional markets to global macroeconomic and geopolitical developments as they enter the final quarter of the year.
Sources: Business Standard, South China Morning Post, Korea JoongAng Daily, Reuters, Xinhua News Agency, Bloomberg, RTTNews, and regional market data as of September 26–27, 2025.
Explore more exclusive insights at nextfin.ai.
